To identify novel immune cell types that express GZMB, we conducted mass cytometry analysis in 12 resected stage II or III CRC tumors using a comprehensive panel of 37 lineage and functional markers of immune populations (S4 Table). This evidence concerns the gene GZMB and colorectal carcinoma.